Features and Functionalities of Smartphone Apps Related to COVID-19: Systematic Search in App Stores and Content Analysis.


Journal

Journal of medical Internet research
ISSN: 1438-8871
Titre abrégé: J Med Internet Res
Pays: Canada
ID NLM: 100959882

Informations de publication

Date de publication:
25 08 2020
Historique:
received: 17 05 2020
accepted: 01 07 2020
revised: 01 07 2020
pubmed: 3 7 2020
medline: 5 9 2020
entrez: 3 7 2020
Statut: epublish

Résumé

Knowledge of the quantity and quality of apps related to coronavirus disease (COVID-19) is lacking. In addition, no directory has been established listing all the apps developed to address the COVID-19 pandemic. The aim of this study was to identify smartphone apps designed to address the COVID-19 pandemic and to analyze their characteristics. We performed an observational, cross-sectional, descriptive study of all smartphone apps associated with COVID-19. Between April 27 and May 2, 2020, we searched the App Store (iOS) and Google Play Store (Android) for COVID-19 apps. The search terms used were coronavirus, COVID-19, and SARS-COV-2. The apps were downloaded and evaluated. The variables analyzed were name, platform, country, language, category, cost, update date, size, version, number of downloads, developer, and purpose. Purpose was further classified into the following categories: news, general information, self-diagnosis, contact tracing, notices to contacts, notification of close cases, awareness, helplines, monitoring of clinical parameters, recording of symptoms and treatment, and messaging with health care professionals. We identified 114 apps on the investigated platforms. Of these, 62/114 (54.4%) were on Android and 52/114 (45.6%) were on iOS. Of the 114 apps, 37 (32.5%) were developed in Europe, 32 (28.1%) in Asia, and 30 (26.3%) in North America. The most frequent languages were English (65/114, 57.0%), Spanish (34/114, 29.8%), and Chinese (14/114, 12.3%). The most common categories were health and well-being/fitness apps (41/114, 41.2%) and medicine apps (43/114, 37.7%). Of the 114 apps, 113 (99.1%) were free. The mean time between the date of the analysis and the date of the last update was 11.1 days (SD 11.0). Overall, 95 of the 114 apps (83.3%) were intended for the general population, 99 apps (7.9%) were intended for health professionals, and 3 apps (2.6%) were intended for both. Regarding the type of developer, 64/114 apps (56.1%) were developed by governments; 42/114 (64.1%) were developed by national governments, and 23/114 (35.9%) were developed by regional governments. The apps with the highest number of downloads (100,000+) were developed by governments (P=.13), except for the World Health Organization app (500,000+). The purposes of the apps available in Western languages (107/114, 93.9%) were determined; the most common purposes were general information about COVID-19 (66, 64.0%), COVID-19 news (53, 51.0%), recording of symptoms (53, 51.0%), and contact tracing (51, 47.7%). More than one purpose was identified for 99/107 apps (92.5%). This paper offers a comprehensive and unique review of all available COVID-19 apps. Governments have adopted these tools during the pandemic, and more than half of the apps were developed by government agencies. The most common purposes of the apps are providing information on the numbers of infected, recovered, and deceased patients, recording of symptoms, and contact tracing.

Sections du résumé

BACKGROUND
Knowledge of the quantity and quality of apps related to coronavirus disease (COVID-19) is lacking. In addition, no directory has been established listing all the apps developed to address the COVID-19 pandemic.
OBJECTIVE
The aim of this study was to identify smartphone apps designed to address the COVID-19 pandemic and to analyze their characteristics.
METHODS
We performed an observational, cross-sectional, descriptive study of all smartphone apps associated with COVID-19. Between April 27 and May 2, 2020, we searched the App Store (iOS) and Google Play Store (Android) for COVID-19 apps. The search terms used were coronavirus, COVID-19, and SARS-COV-2. The apps were downloaded and evaluated. The variables analyzed were name, platform, country, language, category, cost, update date, size, version, number of downloads, developer, and purpose. Purpose was further classified into the following categories: news, general information, self-diagnosis, contact tracing, notices to contacts, notification of close cases, awareness, helplines, monitoring of clinical parameters, recording of symptoms and treatment, and messaging with health care professionals.
RESULTS
We identified 114 apps on the investigated platforms. Of these, 62/114 (54.4%) were on Android and 52/114 (45.6%) were on iOS. Of the 114 apps, 37 (32.5%) were developed in Europe, 32 (28.1%) in Asia, and 30 (26.3%) in North America. The most frequent languages were English (65/114, 57.0%), Spanish (34/114, 29.8%), and Chinese (14/114, 12.3%). The most common categories were health and well-being/fitness apps (41/114, 41.2%) and medicine apps (43/114, 37.7%). Of the 114 apps, 113 (99.1%) were free. The mean time between the date of the analysis and the date of the last update was 11.1 days (SD 11.0). Overall, 95 of the 114 apps (83.3%) were intended for the general population, 99 apps (7.9%) were intended for health professionals, and 3 apps (2.6%) were intended for both. Regarding the type of developer, 64/114 apps (56.1%) were developed by governments; 42/114 (64.1%) were developed by national governments, and 23/114 (35.9%) were developed by regional governments. The apps with the highest number of downloads (100,000+) were developed by governments (P=.13), except for the World Health Organization app (500,000+). The purposes of the apps available in Western languages (107/114, 93.9%) were determined; the most common purposes were general information about COVID-19 (66, 64.0%), COVID-19 news (53, 51.0%), recording of symptoms (53, 51.0%), and contact tracing (51, 47.7%). More than one purpose was identified for 99/107 apps (92.5%).
CONCLUSIONS
This paper offers a comprehensive and unique review of all available COVID-19 apps. Governments have adopted these tools during the pandemic, and more than half of the apps were developed by government agencies. The most common purposes of the apps are providing information on the numbers of infected, recovered, and deceased patients, recording of symptoms, and contact tracing.

Identifiants

pubmed: 32614777
pii: v22i8e20334
doi: 10.2196/20334
pmc: PMC7479586
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e20334

Informations de copyright

©Roberto Collado-Borrell, Vicente Escudero-Vilaplana, Cristina Villanueva-Bueno, Ana Herranz-Alonso, Maria Sanjurjo-Saez. Originally published in the Journal of Medical Internet Research (http://www.jmir.org), 25.08.2020.

Références

JMIR Mhealth Uhealth. 2020 Apr 20;8(4):e19359
pubmed: 32294052
Cancer Epidemiol Biomarkers Prev. 2020 Jul;29(7):1283-1289
pubmed: 32371551
J Oncol Pharm Pract. 2020 Jan;26(1):105-115
pubmed: 30955468
JMIR Mhealth Uhealth. 2020 Apr 7;8(4):e18936
pubmed: 32240973
Science. 2020 Jun 19;368(6497):1362-1367
pubmed: 32371477
Farm Hosp. 2016 Jan 01;40(1):25-35
pubmed: 26882831
J Med Internet Res. 2018 Oct 23;20(10):e11006
pubmed: 30355554
JMIR Public Health Surveill. 2020 Apr 14;6(2):e18668
pubmed: 32250958
J Med Ethics. 2020 Jul;46(7):427-431
pubmed: 32366705
Farm Hosp. 2014 Apr 01;38(2):112-7
pubmed: 24669895
J Clin Oncol. 2016 Feb 20;34(6):557-65
pubmed: 26644527
BMJ. 2020 Mar 27;368:m1263
pubmed: 32220898
Int J Environ Res Public Health. 2020 Apr 23;17(8):
pubmed: 32340107
Int J Health Geogr. 2020 Mar 11;19(1):8
pubmed: 32160889
Clin Infect Dis. 2020 Jul 28;71(15):825-832
pubmed: 32277759
J Eur Acad Dermatol Venereol. 2020 Aug;34(8):e348-e350
pubmed: 32330322

Auteurs

Roberto Collado-Borrell (R)

Hospital General Universitario Gregorio Marañón, Madrid, Spain.

Vicente Escudero-Vilaplana (V)

Hospital General Universitario Gregorio Marañón, Madrid, Spain.

Cristina Villanueva-Bueno (C)

Hospital General Universitario Gregorio Marañón, Madrid, Spain.

Ana Herranz-Alonso (A)

Hospital General Universitario Gregorio Marañón, Madrid, Spain.

Maria Sanjurjo-Saez (M)

Hospital General Universitario Gregorio Marañón, Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH